1.21
Innovation
Repurposing a proven gene therapy approach to treat, prevent COVID-19
In a Q&A, Penn Medicine’s James M. Wilson discusses using adeno-associated viral vectors to transport a lab-made antibody cocktail into the body. This method, delivered via nasal spray or mist, has the potential to act as a “bioshield” against SARS-CoV-2.
Organoids to rebuild the brain
Penn neuroscientists are developing innovative ways to treat neurological diseases, including implanting neural tissue like a brain organoid to rebuild brain circuitry.
Translating groundbreaking scientific discoveries into practical technologies
Amidst the numerous challenges posed by COVID-19, the Penn Center for Innovation has continued to facilitate impactful innovations created at Penn, fostering partnerships and helping to realize new products and businesses.
Embracing digital dentistry
The School of Dental Medicine is enhancing and integrating its digital capabilities, opening up new possibilities for training students, conducting research, and delivering seamless and cutting-edge patient care.
If pandemic productivity is up, why is innovation slowing down?
A new study finds that productivity has remained stable or even increased for many companies that shifted to remote work during the coronavirus pandemic. However, innovation has taken a hit as both leaders and employees feel more distant from each other.
Uniting against an invisible foe
All across the University, researchers have launched new areas of study, reaching across disciplinary boundaries to make stunning progress in combating COVID-19.
Using lung-on-a-chip technology to find treatments for chlorine gas exposure
The new lung-on-a-chip platforms will help better understand how chlorine damages lung tissues and to discover specific biomarkers of chlorine gas-induced lung injury.
Penn Nursing’s innovation ecosystem
In the past five years, the school has been intentional about creating an atmosphere that rewards risk-taking and supports failures. It’s led to story slams and accelerators and a shift to an innovation-centric mindset.
An ecosystem of innovation fosters tech-based solutions to COVID-19 challenges
Clinicians, engineers, and IT specialists work together at Penn on innovations that help doctors provide the best care for patients amid continued social distancing and coronavirus restrictions.
Nanoparticles can turn off genes in bone marrow
Using specialized nanoparticles, researchers from Penn Engineering and MIT have developed a way to turn off specific genes in cells of bone marrow, which play an important role in producing blood cells.
In the News
Leggy bots, flying bots, building bots: Here’s what Penn’s robotics hub is up to
School of Engineering and Applied Science students past and present, including Gavin Kenneally, Daniel Mellinger, Divya Ramesh, Mickey Whitzer, and Chao Liu, were highlighted for their work at the Pennovation Center. Their efforts were showcased at Philly Tech Week.
FULL STORY →
A new research center at Wharton wants to make a fintech hub out of Philly
The Wharton School’s David Musto will be heading the new Stevens Center for Innovation in Finance, which will offer research courses and mentorship to students pursuing careers in the fintech sector. “Penn’s unique mission has always been to take on the biggest real-world challenges and opportunities through knowledge-based and data-driven innovation,” said President Amy Gutmann.
FULL STORY →
Second (science) city no more
Kevin Mahoney of the Perelman School of Medicine and the Health System said Philadelphia is “creating new history” with its efforts to catch up to other major cities known for innovation. Penn is leading the way with investments designed to create jobs, fund research, and keep talent local.
FULL STORY →
Penn Makes Third Big Biotech Bet, Helping to Raise $53M for Carisma
Cancer-fighting biotech company Carisma Therapeutics Inc. is the latest addition to Penn’s recently-announced investment plan. Roy Rosin, CIO at Penn Medicine, said, “Penn’s commitment is pretty exciting for this region.”
FULL STORY →
Penn Invests $50 million in Biotech in a Bold Bid to Build Philly’s Innovation Cluster
Kevin B. Mahoney of the Perelman School of Medicine and UPHS confirmed Penn’s plans to invest in biotech companies, with long-range goals “to create jobs, synergy and an innovation cluster around Penn technology and spin outs.”
FULL STORY →